Pharmaceutical Contract Manufacturing Market – Global Industry Analysis and Forecast (2023–2029)


Pharmaceutical Contract Manufacturing Market is expected to reach US$ 196.12 Bn. at a CAGR of 7% during the forecast period 2029.

Pharmaceutical Contract Manufacturing Market Definition:

The Pharmaceutical contract manufacturing is an organization that serves the pharmaceutical industry and offers clients with comprehensive services from drug development over drug manufacturing.Pharmaceutical Contract Manufacturing MarketTo know about the Research Methodology :- Request Free Sample Report

The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.

Global Pharmaceutical Contract Manufacturing Market Dynamics:

The scope of the report includes a detailed study of global and regional markets for the market with the reasons given for variations in the growth of the industry in certain regions. Pharmaceutical major players are increasingly relying on contract manufacturing, packaging services, and research to fulfill many basic needs and competencies.

The companies endeavor to save costs and product development time while simultaneously being productive and efficient. Many dynamics in the pharma arena are influencing companies’ development and manufacturing strategies. On the other hand, the introduction of serialization and changing trade policies between economies are major market challenges.

Ongoing Trends:

The report covers all the trends playing a major role in the growth of the market over the forecast period. A key trend in biotechnology contract manufacturing is merging in the pharmaceutical contract manufacturing like in 2022 Thermo Fisher Scientific completed the acquisition of Patheon, making the world’s most comprehensive and sophisticated end to end CDMO partner.

Global Pharmaceutical Contract Manufacturing Market Segmentation:

Based on service, pharmaceutical API manufacturing segment is expected to grow at the highest xx% CAGR during the forecast period. Pharmaceutical API manufacturing dominated in terms of revenue because of the growing demand for high potency active pharmaceutical ingredients (HPAPI). Similarly, the report covers the segments in the markets such as service and end-user.

Region-wise Analysis:

The report offers a brief analysis of the major regions in the market, namely, APAC, Europe, North America, South America, and the MEA. North America’s pharmaceutical contract manufacturing market was valued at US$ xx Mn. in 2022 and is expected to reach a value of US$ xx Mn. by 2029, with a CAGR of xx% during the forecast period. The presence of a strong CRO segment in the region and the growing popularity of CMOs in the U.S and Mexico will significantly fuel the market growth in North America over the forecast period.

Global Pharmaceutical Contract Manufacturing Market Competitive Landscape:

The competitive landscape section in the pharmaceutical contract manufacturing market offers a deep dive into the profiles of the leading players operating in the global market landscape. It offers captivating insights on the key developments, differential strategies, and other crucial aspects of the companies having a stronghold in the market. In Feb 2021, Catalent has signed a contract with Zumutor Biologics, Inc, to manufacture Zumutor’s, ZM008, for the treatment of solid tumors. Zumutor is a biologics company that develops new Immuno-oncotherapeutics to drive transformational developments in cancer treatment.

The objective of the report is to present a comprehensive analysis of the Global Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding Global Market dynamics, structure by analyzing the market segments and projects the Global Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Pharmaceutical Contract Manufacturing Market make the report investor’s guide.

Global Pharmaceutical Contract Manufacturing Market Scope: Inquire before buying






Global Pharmaceutical Contract Manufacturing Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2018 to 2022
Market Size in 2022:
US $ 122.13 Bn.




Forecast Period 2023 to 2029 CAGR:
7%
Market Size in 2029:
US $ 196.12 Bn.




 Segments Covered:
by Service
Pharmaceutical Manufacturing Services
Biologics Manufacturing Services
Drug Development Services




by End User
Big Pharma
Small & Mid-size Pharma
Generic Pharmaceutical Companies
Other End Users






Global Pharmaceutical Contract Manufacturing Market, by Region

Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Key players

1. Thermo Fisher Scientific Inc.
2. Catalent, Inc.
3. Lonza Group Ltd
4. Recipharm AB
5. Vetter Pharma International GmbH
6. Famar Health Care Services
7. Abbvie Inc.
8. Aenova Group
9. Consort Medical Plc
10. Almac Group
11. Siegfried Holding AG
12. Evonik Industries AG
13. Boehringer Ingelheim International GmbH
14. Beijing Landscape
15. Bushu Pharmaceuticals
16. Porton Fine Chemicals
17. Pfizer
18. Tianjin Pharmaceuticals
19. Recipharm
20. Catalent

Frequently Asked Questions:

1. Which region has the largest share in Global Pharmaceutical Contract Manufacturing Market?
Ans: North America region holds the highest share in 2022.

2. What is the growth rate of Global Pharmaceutical Contract Manufacturing Market?
Ans: The Global Market is growing at a CAGR of 7% during forecasting period 2023-2029.

3. What is scope of the Global Pharmaceutical Contract Manufacturing market report?
Ans: Global Pharmaceutical Contract Manufacturing Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Pharmaceutical Contract Manufacturing market?
Ans: The important key players in the Global Market are – Thermo Fisher Scientific Inc., Catalent, Inc., Lonza Group Ltd, Recipharm AB, Vetter Pharma International GmbH, Famar Health Care Services, Abbvie Inc., Aenova Group, Consort Medical Plc, Almac Group, Siegfried Holding AG, Evonik Industries AG, Boehringer Ingelheim International GmbH, Beijing Landscape, Bushu Pharmaceuticals, Porton Fine Chemicals, Pfizer, Tianjin Pharmaceuticals, Recipharm, and Catalent

5. What is the study period of this market?
Ans: The Global Pharmaceutical Contract Manufacturing Market is studied from 2022 to 2029. 




Global Pharmaceutical Contract Manufacturing Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: Global Pharmaceutical Contract Manufacturing Market Size, by Market Value (US$ Bn)

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies

5. Supply Side and Demand Side Indicators
6. Global Pharmaceutical Contract Manufacturing Market Analysis and Forecast
6.1. Pharmaceutical Contract Manufacturing Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global Pharmaceutical Contract Manufacturing Market Analysis and Forecast, by End User
7.1. Introduction and Definition
7.2. Key Findings
7.3. Pharmaceutical Contract Manufacturing Market Value Share Analysis, by End User
7.4. Pharmaceutical Contract Manufacturing Market Size (US$ Bn) Forecast, by End User
7.5. Pharmaceutical Contract Manufacturing Market Analysis, by End User
7.6. Pharmaceutical Contract Manufacturing Market Attractiveness Analysis, by End User

8. Global Pharmaceutical Contract Manufacturing Market Analysis and Forecast, by Service
8.1. Introduction and Definition
8.2. Key Findings
8.3. Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Service
8.4. Pharmaceutical Contract Manufacturing Market Size (US$ Bn) Forecast, by Service
8.5. Pharmaceutical Contract Manufacturing Market Analysis, by Service
8.6. Pharmaceutical Contract Manufacturing Market Attractiveness Analysis, by Service

9. Global Pharmaceutical Contract Manufacturing Market Analysis, by Region
9.1. Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Region
9.2. Pharmaceutical Contract Manufacturing Market Size (US$ Bn) Forecast, by Region
9.3. Pharmaceutical Contract Manufacturing Market Attractiveness Analysis, by Region

10. North America Pharmaceutical Contract Manufacturing Market Analysis
10.1. Key Findings
10.2. North America Pharmaceutical Contract Manufacturing Market Overview
10.3. North America Pharmaceutical Contract Manufacturing Market Value Share Analysis, by End User
10.4. North America Pharmaceutical Contract Manufacturing Market Forecast, by End User
10.4.1. Big Pharma
10.4.2. Small & Mid-size Pharma
10.4.3. Generic Pharmaceutical Companies
10.4.4. Other End Users
10.5. North America Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Service
10.6. North America Pharmaceutical Contract Manufacturing Market Forecast, by Service
10.6.1. Pharmaceutical Manufacturing Services
10.6.1.1. Pharmaceutical API Manufacturing
10.6.1.2. Pharmaceutical FDF Manufacturing
10.6.1.2.1. Parenteral/Injectable
10.6.1.2.2. Tablet
10.6.1.2.3. Capsule
10.6.1.2.4. Oral Liquid
10.6.1.2.5. Other Formulations
10.6.2. Biologics Manufacturing Services
10.6.2.1. Biologics API Manufacturing
10.6.2.2. Biologics FDF Manufacturing
10.6.3. Drug Development Services
10.7. North America Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Country
10.8. North America Pharmaceutical Contract Manufacturing Market Forecast, by Country
10.8.1. The U.S.
10.8.2. Canada
10.9. North America Pharmaceutical Contract Manufacturing Market Analysis, by Country
10.10. U.S. Pharmaceutical Contract Manufacturing Market Forecast, by End User
10.10.1. Big Pharma
10.10.2. Small & Mid-size Pharma
10.10.3. Generic Pharmaceutical Companies
10.10.4. Other End Users
10.11. U.S. Pharmaceutical Contract Manufacturing Market Forecast, by Service
10.11.1. Pharmaceutical Manufacturing Services
10.11.1.1. Pharmaceutical API Manufacturing
10.11.1.2. Pharmaceutical FDF Manufacturing
10.11.1.2.1. Parenteral/Injectable
10.11.1.2.2. Tablet
10.11.1.2.3. Capsule
10.11.1.2.4. Oral Liquid
10.11.1.2.5. Other Formulations
10.11.2. Biologics Manufacturing Services
10.11.2.1. Biologics API Manufacturing
10.11.2.2. Biologics FDF Manufacturing
10.11.3. Drug Development Services
10.12. Canada Pharmaceutical Contract Manufacturing Market Forecast, by End User
10.12.1. Big Pharma
10.12.2. Small & Mid-size Pharma
10.12.3. Generic Pharmaceutical Companies
10.12.4. Other End Users
10.13. Canada Pharmaceutical Contract Manufacturing Market Forecast, by Service
10.13.1. Pharmaceutical Manufacturing Services
10.13.1.1. Pharmaceutical API Manufacturing
10.13.1.2. Pharmaceutical FDF Manufacturing
10.13.1.2.1. Parenteral/Injectable
10.13.1.2.2. Tablet
10.13.1.2.3. Capsule
10.13.1.2.4. Oral Liquid
10.13.1.2.5. Other Formulations
10.13.2. Biologics Manufacturing Services
10.13.2.1. Biologics API Manufacturing
10.13.2.2. Biologics FDF Manufacturing
10.13.3. Drug Development Services
10.14. North America Pharmaceutical Contract Manufacturing Market Attractiveness Analysis
10.14.1. By End User
10.14.2. By Service
10.15. PEST Analysis
10.16. Key Trends
10.17. Key Developments

11. Europe Pharmaceutical Contract Manufacturing Market Analysis
11.1. Key Findings
11.2. Europe Pharmaceutical Contract Manufacturing Market Overview
11.3. Europe Pharmaceutical Contract Manufacturing Market Value Share Analysis, by End User
11.4. Europe Pharmaceutical Contract Manufacturing Market Forecast, by End User
11.4.1. Big Pharma
11.4.2. Small & Mid-size Pharma
11.4.3. Generic Pharmaceutical Companies
11.4.4. Other End Users
11.5. Europe Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Service
11.6. Europe Pharmaceutical Contract Manufacturing Market Forecast, by Service
11.6.1. Pharmaceutical Manufacturing Services
11.6.1.1. Pharmaceutical API Manufacturing
11.6.1.2. Pharmaceutical FDF Manufacturing
11.6.1.2.1. Parenteral/Injectable
11.6.1.2.2. Tablet
11.6.1.2.3. Capsule
11.6.1.2.4. Oral Liquid
11.6.1.2.5. Other Formulations
11.6.2. Biologics Manufacturing Services
11.6.2.1. Biologics API Manufacturing
11.6.2.2. Biologics FDF Manufacturing
11.6.3. Drug Development Services
11.7. Europe Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Country
11.8. Europe Pharmaceutical Contract Manufacturing Market Forecast, by Country
11.8.1. Germany
11.8.2. The U.K.
11.8.3. France
11.8.4. Italy
11.8.5. Spain
11.8.6. Rest of Europe
11.9. Europe Pharmaceutical Contract Manufacturing Market Analysis, by Country
11.10. Germany Pharmaceutical Contract Manufacturing Market Forecast, by End User
11.10.1. Big Pharma
11.10.2. Small & Mid-size Pharma
11.10.3. Generic Pharmaceutical Companies
11.10.4. Other End Users
11.11. Germany Pharmaceutical Contract Manufacturing Market Forecast, by Service
11.11.1. Pharmaceutical Manufacturing Services
11.11.1.1. Pharmaceutical API Manufacturing
11.11.1.2. Pharmaceutical FDF Manufacturing
11.11.1.2.1. Parenteral/Injectable
11.11.1.2.2. Tablet
11.11.1.2.3. Capsule
11.11.1.2.4. Oral Liquid
11.11.1.2.5. Other Formulations
11.11.2. Biologics Manufacturing Services
11.11.2.1. Biologics API Manufacturing
11.11.2.2. Biologics FDF Manufacturing
11.11.3. Drug Development Services
11.12. U.K. Pharmaceutical Contract Manufacturing Market Forecast, by End User
11.12.1. Big Pharma
11.12.2. Small & Mid-size Pharma
11.12.3. Generic Pharmaceutical Companies
11.12.4. Other End Users
11.13. U.K. Pharmaceutical Contract Manufacturing Market Forecast, by Service
11.13.1. Pharmaceutical Manufacturing Services
11.13.1.1. Pharmaceutical API Manufacturing
11.13.1.2. Pharmaceutical FDF Manufacturing
11.13.1.2.1. Parenteral/Injectable
11.13.1.2.2. Tablet
11.13.1.2.3. Capsule
11.13.1.2.4. Oral Liquid
11.13.1.2.5. Other Formulations
11.13.2. Biologics Manufacturing Services
11.13.2.1. Biologics API Manufacturing
11.13.2.2. Biologics FDF Manufacturing
11.13.3. Drug Development Services
11.14. France Pharmaceutical Contract Manufacturing Market Forecast, by End User
11.14.1. Big Pharma
11.14.2. Small & Mid-size Pharma
11.14.3. Generic Pharmaceutical Companies
11.14.4. Other End Users
11.15. France Pharmaceutical Contract Manufacturing Market Forecast, by Service
11.15.1. Pharmaceutical Manufacturing Services
11.15.1.1. Pharmaceutical API Manufacturing
11.15.1.2. Pharmaceutical FDF Manufacturing
11.15.1.2.1. Parenteral/Injectable
11.15.1.2.2. Tablet
11.15.1.2.3. Capsule
11.15.1.2.4. Oral Liquid
11.15.1.2.5. Other Formulations
11.15.2. Biologics Manufacturing Services
11.15.2.1. Biologics API Manufacturing
11.15.2.2. Biologics FDF Manufacturing
11.15.3. Drug Development Services
11.16. Italy Pharmaceutical Contract Manufacturing Market Forecast, by End User
11.16.1. Big Pharma
11.16.2. Small & Mid-size Pharma
11.16.3. Generic Pharmaceutical Companies
11.16.4. Other End Users
11.17. Italy Pharmaceutical Contract Manufacturing Market Forecast, by Service
11.17.1. Pharmaceutical Manufacturing Services
11.17.1.1. Pharmaceutical API Manufacturing
11.17.1.2. Pharmaceutical FDF Manufacturing
11.17.1.2.1. Parenteral/Injectable
11.17.1.2.2. Tablet
11.17.1.2.3. Capsule
11.17.1.2.4. Oral Liquid
11.17.1.2.5. Other Formulations
11.17.2. Biologics Manufacturing Services
11.17.2.1. Biologics API Manufacturing
11.17.2.2. Biologics FDF Manufacturing
11.17.3. Drug Development Services
11.18. Spain Pharmaceutical Contract Manufacturing Market Forecast, by End User
11.18.1. Big Pharma
11.18.2. Small & Mid-size Pharma
11.18.3. Generic Pharmaceutical Companies
11.18.4. Other End Users
11.19. Spain Pharmaceutical Contract Manufacturing Market Forecast, by Service
11.19.1. Pharmaceutical Manufacturing Services
11.19.1.1. Pharmaceutical API Manufacturing
11.19.1.2. Pharmaceutical FDF Manufacturing
11.19.1.2.1. Parenteral/Injectable
11.19.1.2.2. Tablet
11.19.1.2.3. Capsule
11.19.1.2.4. Oral Liquid
11.19.1.2.5. Other Formulations
11.19.2. Biologics Manufacturing Services
11.19.2.1. Biologics API Manufacturing
11.19.2.2. Biologics FDF Manufacturing
11.19.3. Drug Development Services
11.20. Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, by End User
11.20.1. Big Pharma
11.20.2. Small & Mid-size Pharma
11.20.3. Generic Pharmaceutical Companies
11.20.4. Other End Users
11.21. Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, by Service
11.21.1. Pharmaceutical Manufacturing Services
11.21.1.1. Pharmaceutical API Manufacturing
11.21.1.2. Pharmaceutical FDF Manufacturing
11.21.1.2.1. Parenteral/Injectable
11.21.1.2.2. Tablet
11.21.1.2.3. Capsule
11.21.1.2.4. Oral Liquid
11.21.1.2.5. Other Formulations
11.21.2. Biologics Manufacturing Services
11.21.2.1. Biologics API Manufacturing
11.21.2.2. Biologics FDF Manufacturing
11.21.3. Drug Development Services
11.22. Europe Pharmaceutical Contract Manufacturing Market Attractiveness Analysis
11.22.1. By End User
11.22.2. By Service
11.23. PEST Analysis
11.24. Key Trends
11.25. Key Developments

12. Asia Pacific Pharmaceutical Contract Manufacturing Market Analysis
12.1. Key Findings
12.2. Asia Pacific Pharmaceutical Contract Manufacturing Market Overview
12.3. Asia Pacific Pharmaceutical Contract Manufacturing Market Value Share Analysis, by End User
12.4. Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast, by End User
12.4.1. Big Pharma
12.4.2. Small & Mid-size Pharma
12.4.3. Generic Pharmaceutical Companies
12.4.4. Other End Users
12.5. Asia Pacific Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Service
12.6. Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast, by Service
12.6.1. Pharmaceutical Manufacturing Services
12.6.1.1. Pharmaceutical API Manufacturing
12.6.1.2. Pharmaceutical FDF Manufacturing
12.6.1.2.1. Parenteral/Injectable
12.6.1.2.2. Tablet
12.6.1.2.3. Capsule
12.6.1.2.4. Oral Liquid
12.6.1.2.5. Other Formulations
12.6.2. Biologics Manufacturing Services
12.6.2.1. Biologics API Manufacturing
12.6.2.2. Biologics FDF Manufacturing
12.6.3. Drug Development Services
12.7. Asia Pacific Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Country
12.8. Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast, by Country
12.8.1. China
12.8.2. India
12.8.3. Japan
12.8.4. ASEAN
12.8.5. Rest of Asia Pacific
12.9. Asia Pacific Pharmaceutical Contract Manufacturing Market Analysis, by Country
12.10. China Pharmaceutical Contract Manufacturing Market Forecast, by End User
12.10.1. Big Pharma
12.10.2. Small & Mid-size Pharma
12.10.3. Generic Pharmaceutical Companies
12.10.4. Other End Users
12.11. China Pharmaceutical Contract Manufacturing Market Forecast, by Service
12.11.1. Pharmaceutical Manufacturing Services
12.11.1.1. Pharmaceutical API Manufacturing
12.11.1.2. Pharmaceutical FDF Manufacturing
12.11.1.2.1. Parenteral/Injectable
12.11.1.2.2. Tablet
12.11.1.2.3. Capsule
12.11.1.2.4. Oral Liquid
12.11.1.2.5. Other Formulations
12.11.2. Biologics Manufacturing Services
12.11.2.1. Biologics API Manufacturing
12.11.2.2. Biologics FDF Manufacturing
12.11.3. Drug Development Services
12.12. India Pharmaceutical Contract Manufacturing Market Forecast, by End User
12.12.1. Big Pharma
12.12.2. Small & Mid-size Pharma
12.12.3. Generic Pharmaceutical Companies
12.12.4. Other End Users
12.13. India Pharmaceutical Contract Manufacturing Market Forecast, by Service
12.13.1. Pharmaceutical Manufacturing Services
12.13.1.1. Pharmaceutical API Manufacturing
12.13.1.2. Pharmaceutical FDF Manufacturing
12.13.1.2.1. Parenteral/Injectable
12.13.1.2.2. Tablet
12.13.1.2.3. Capsule
12.13.1.2.4. Oral Liquid
12.13.1.2.5. Other Formulations
12.13.2. Biologics Manufacturing Services
12.13.2.1. Biologics API Manufacturing
12.13.2.2. Biologics FDF Manufacturing
12.13.3. Drug Development Services
12.14. Japan Pharmaceutical Contract Manufacturing Market Forecast, by End User
12.14.1. Big Pharma
12.14.2. Small & Mid-size Pharma
12.14.3. Generic Pharmaceutical Companies
12.14.4. Other End Users
12.15. Japan Pharmaceutical Contract Manufacturing Market Forecast, by Service
12.15.1. Pharmaceutical Manufacturing Services
12.15.1.1. Pharmaceutical API Manufacturing
12.15.1.2. Pharmaceutical FDF Manufacturing
12.15.1.2.1. Parenteral/Injectable
12.15.1.2.2. Tablet
12.15.1.2.3. Capsule
12.15.1.2.4. Oral Liquid
12.15.1.2.5. Other Formulations
12.15.2. Biologics Manufacturing Services
12.15.2.1. Biologics API Manufacturing
12.15.2.2. Biologics FDF Manufacturing
12.15.3. Drug Development Services
12.16. ASEAN Pharmaceutical Contract Manufacturing Market Forecast, by End User
12.16.1. Big Pharma
12.16.2. Small & Mid-size Pharma
12.16.3. Generic Pharmaceutical Companies
12.16.4. Other End Users
12.17. ASEAN Pharmaceutical Contract Manufacturing Market Forecast, by Service
12.17.1. Pharmaceutical Manufacturing Services
12.17.1.1. Pharmaceutical API Manufacturing
12.17.1.2. Pharmaceutical FDF Manufacturing
12.17.1.2.1. Parenteral/Injectable
12.17.1.2.2. Tablet
12.17.1.2.3. Capsule
12.17.1.2.4. Oral Liquid
12.17.1.2.5. Other Formulations
12.17.2. Biologics Manufacturing Services
12.17.2.1. Biologics API Manufacturing
12.17.2.2. Biologics FDF Manufacturing
12.17.3. Drug Development Services
12.18. Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast, by End User
12.18.1. Big Pharma
12.18.2. Small & Mid-size Pharma
12.18.3. Generic Pharmaceutical Companies
12.18.4. Other End Users
12.19. Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast, by Service
12.19.1. Pharmaceutical Manufacturing Services
12.19.1.1. Pharmaceutical API Manufacturing
12.19.1.2. Pharmaceutical FDF Manufacturing
12.19.1.2.1. Parenteral/Injectable
12.19.1.2.2. Tablet
12.19.1.2.3. Capsule
12.19.1.2.4. Oral Liquid
12.19.1.2.5. Other Formulations
12.19.2. Biologics Manufacturing Services
12.19.2.1. Biologics API Manufacturing
12.19.2.2. Biologics FDF Manufacturing
12.19.3. Drug Development Services
12.20. Asia Pacific Pharmaceutical Contract Manufacturing Market Attractiveness Analysis
12.20.1. By End User
12.20.2. By Service
12.21. PEST Analysis
12.22. Key Trends
12.23. Key Developments

13. Middle East & Africa Pharmaceutical Contract Manufacturing Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Pharmaceutical Contract Manufacturing Market Overview
13.3. Middle East & Africa Pharmaceutical Contract Manufacturing Market Value Share Analysis, by End User
13.4. Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast, by End User
13.4.1. Big Pharma
13.4.2. Small & Mid-size Pharma
13.4.3. Generic Pharmaceutical Companies
13.4.4. Other End Users
13.5. Middle East & Africa Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Service
13.6. Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast, by Service
13.6.1. Pharmaceutical Manufacturing Services
13.6.1.1. Pharmaceutical API Manufacturing
13.6.1.2. Pharmaceutical FDF Manufacturing
13.6.1.2.1. Parenteral/Injectable
13.6.1.2.2. Tablet
13.6.1.2.3. Capsule
13.6.1.2.4. Oral Liquid
13.6.1.2.5. Other Formulations
13.6.2. Biologics Manufacturing Services
13.6.2.1. Biologics API Manufacturing
13.6.2.2. Biologics FDF Manufacturing
13.6.3. Drug Development Services
13.7. Middle East & Africa Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Country
13.8. Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast, by Country
13.8.1. GCC
13.8.2. South Africa
13.8.3. Rest of Middle East & Africa
13.9. Middle East & Africa Pharmaceutical Contract Manufacturing Market Analysis, by Country
13.10. GCC Pharmaceutical Contract Manufacturing Market Forecast, by End User
13.10.1. Big Pharma
13.10.2. Small & Mid-size Pharma
13.10.3. Generic Pharmaceutical Companies
13.10.4. Other End Users
13.11. GCC Pharmaceutical Contract Manufacturing Market Forecast, by Service
13.11.1. Pharmaceutical Manufacturing Services
13.11.1.1. Pharmaceutical API Manufacturing
13.11.1.2. Pharmaceutical FDF Manufacturing
13.11.1.2.1. Parenteral/Injectable
13.11.1.2.2. Tablet
13.11.1.2.3. Capsule
13.11.1.2.4. Oral Liquid
13.11.1.2.5. Other Formulations
13.11.2. Biologics Manufacturing Services
13.11.2.1. Biologics API Manufacturing
13.11.2.2. Biologics FDF Manufacturing
13.11.3. Drug Development Services
13.12. South Africa Pharmaceutical Contract Manufacturing Market Forecast, by End User
13.12.1. Big Pharma
13.12.2. Small & Mid-size Pharma
13.12.3. Generic Pharmaceutical Companies
13.12.4. Other End Users
13.13. South Africa Pharmaceutical Contract Manufacturing Market Forecast, by Service
13.13.1. Pharmaceutical Manufacturing Services
13.13.1.1. Pharmaceutical API Manufacturing
13.13.1.2. Pharmaceutical FDF Manufacturing
13.13.1.2.1. Parenteral/Injectable
13.13.1.2.2. Tablet
13.13.1.2.3. Capsule
13.13.1.2.4. Oral Liquid
13.13.1.2.5. Other Formulations
13.13.2. Biologics Manufacturing Services
13.13.2.1. Biologics API Manufacturing
13.13.2.2. Biologics FDF Manufacturing
13.13.3. Drug Development Services
13.14. Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast, by End User
13.14.1. Big Pharma
13.14.2. Small & Mid-size Pharma
13.14.3. Generic Pharmaceutical Companies
13.14.4. Other End Users
13.15. Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast, by Service
13.15.1. Pharmaceutical Manufacturing Services
13.15.1.1. Pharmaceutical API Manufacturing
13.15.1.2. Pharmaceutical FDF Manufacturing
13.15.1.2.1. Parenteral/Injectable
13.15.1.2.2. Tablet
13.15.1.2.3. Capsule
13.15.1.2.4. Oral Liquid
13.15.1.2.5. Other Formulations
13.15.2. Biologics Manufacturing Services
13.15.2.1. Biologics API Manufacturing
13.15.2.2. Biologics FDF Manufacturing
13.15.3. Drug Development Services
13.16. Middle East & Africa Pharmaceutical Contract Manufacturing Market Attractiveness Analysis
13.16.1. By End User
13.16.2. By Service
13.17. PEST Analysis
13.18. Key Trends
13.19. Key Developments

14. South America Pharmaceutical Contract Manufacturing Market Analysis
14.1. Key Findings
14.2. South America Pharmaceutical Contract Manufacturing Market Overview
14.3. South America Pharmaceutical Contract Manufacturing Market Value Share Analysis, by End User
14.4. South America Pharmaceutical Contract Manufacturing Market Forecast, by End User
14.4.1. Big Pharma
14.4.2. Small & Mid-size Pharma
14.4.3. Generic Pharmaceutical Companies
14.4.4. Other End Users
14.5. South America Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Service
14.6. South America Pharmaceutical Contract Manufacturing Market Forecast, by Service
14.6.1. Pharmaceutical Manufacturing Services
14.6.1.1. Pharmaceutical API Manufacturing
14.6.1.2. Pharmaceutical FDF Manufacturing
14.6.1.2.1. Parenteral/Injectable
14.6.1.2.2. Tablet
14.6.1.2.3. Capsule
14.6.1.2.4. Oral Liquid
14.6.1.2.5. Other Formulations
14.6.2. Biologics Manufacturing Services
14.6.2.1. Biologics API Manufacturing
14.6.2.2. Biologics FDF Manufacturing
14.6.3. Drug Development Services
14.7. South America Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Country
14.8. South America Pharmaceutical Contract Manufacturing Market Forecast, by Country
14.8.1. Brazil
14.8.2. Mexico
14.8.3. Rest of South America
14.9. South America Pharmaceutical Contract Manufacturing Market Analysis, by Country
14.10. Brazil Pharmaceutical Contract Manufacturing Market Forecast, by End User
14.10.1. Big Pharma
14.10.2. Small & Mid-size Pharma
14.10.3. Generic Pharmaceutical Companies
14.10.4. Other End Users
14.11. Brazil Pharmaceutical Contract Manufacturing Market Forecast, by Service
14.11.1. Pharmaceutical Manufacturing Services
14.11.1.1. Pharmaceutical API Manufacturing
14.11.1.2. Pharmaceutical FDF Manufacturing
14.11.1.2.1. Parenteral/Injectable
14.11.1.2.2. Tablet
14.11.1.2.3. Capsule
14.11.1.2.4. Oral Liquid
14.11.1.2.5. Other Formulations
14.11.2. Biologics Manufacturing Services
14.11.2.1. Biologics API Manufacturing
14.11.2.2. Biologics FDF Manufacturing
14.11.3. Drug Development Services
14.12. Mexico Pharmaceutical Contract Manufacturing Market Forecast, by End User
14.12.1. Big Pharma
14.12.2. Small & Mid-size Pharma
14.12.3. Generic Pharmaceutical Companies
14.12.4. Other End Users
14.13. Mexico Pharmaceutical Contract Manufacturing Market Forecast, by Service
14.13.1. Pharmaceutical Manufacturing Services
14.13.1.1. Pharmaceutical API Manufacturing
14.13.1.2. Pharmaceutical FDF Manufacturing
14.13.1.2.1. Parenteral/Injectable
14.13.1.2.2. Tablet
14.13.1.2.3. Capsule
14.13.1.2.4. Oral Liquid
14.13.1.2.5. Other Formulations
14.13.2. Biologics Manufacturing Services
14.13.2.1. Biologics API Manufacturing
14.13.2.2. Biologics FDF Manufacturing
14.13.3. Drug Development Services
14.14. Rest of South America Pharmaceutical Contract Manufacturing Market Forecast, by End User
14.14.1. Big Pharma
14.14.2. Small & Mid-size Pharma
14.14.3. Generic Pharmaceutical Companies
14.14.4. Other End Users
14.15. Rest of South America Pharmaceutical Contract Manufacturing Market Forecast, by Service
14.15.1. Pharmaceutical Manufacturing Services
14.15.1.1. Pharmaceutical API Manufacturing
14.15.1.2. Pharmaceutical FDF Manufacturing
14.15.1.2.1. Parenteral/Injectable
14.15.1.2.2. Tablet
14.15.1.2.3. Capsule
14.15.1.2.4. Oral Liquid
14.15.1.2.5. Other Formulations
14.15.2. Biologics Manufacturing Services
14.15.2.1. Biologics API Manufacturing
14.15.2.2. Biologics FDF Manufacturing
14.15.3. Drug Development Services
14.16. South America Pharmaceutical Contract Manufacturing Market Attractiveness Analysis
14.16.1. By End User
14.16.2. By Service
14.17. PEST Analysis
14.18. Key Trends
14.19. Key Developments

15. Company Profiles
15.1. Market Share Analysis, by Company
15.2. Competition Matrix
15.2.1. Competitive Benchmarking of key players by price, presence, market share, Vehicles and R&D investment
15.2.2. New Product Launches and Product Enhancements
15.2.3. Market Consolidation
15.2.3.1. M&A by Regions, Investment and Vehicles
15.2.3.2. M&A Key Players, Forward Integration and Backward
15.2.3.3. Integration
15.3. Company Profiles: Key Players
15.3.1. Thermo Fisher Scientific Inc.
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategy
15.3.1.5. Recent Developments
15.3.1.6. Development Footprint
15.3.2. Catalent, Inc.
15.3.3. Lonza Group Ltd
15.3.4. Recipharm AB
15.3.5. Vetter Pharma International GmbH
15.3.6. Famar Health Care Services
15.3.7. Abbvie Inc.
15.3.8. Aenova Group
15.3.9. Consort Medical Plc
15.3.10. Almac Group
15.3.11. Siegfried Holding AG
15.3.12. Evonik Industries AG
15.3.13. Boehringer Ingelheim International GmbH
15.3.14. Beijing Landscape
15.3.15. Bushu Pharmaceuticals
15.3.16. Porton Fine Chemicals
15.3.17. Pfizer
15.3.18. Tianjin Pharmaceuticals
15.3.19. Recipharm
15.3.20. Catalent
16. Primary Key Insights
  • INQUIRE BEFORE BUYING